Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,402 | N/A | -3,420 | -1,599 | -1,198 |
| Depreciation Amortization | 58 | N/A | 260 | 141 | 154 |
| Accounts receivable | -24 | N/A | -7 | -53 | 2 |
| Accounts payable and accrued liabilities | 241 | N/A | -252 | 51 | 45 |
| Other Working Capital | 92 | N/A | -440 | -377 | -295 |
| Other Operating Activity | 812 | 0 | 362 | 430 | 562 |
| Operating Cash Flow | $-1,223 | $N/A | $-3,497 | $-1,407 | $-730 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -25 | N/A | N/A |
| PPE Investments | -1 | N/A | 642 | 694 | 6 |
| Net Acquisitions | -169 | N/A | N/A | N/A | -148 |
| Purchase Sale Intangibles | N/A | N/A | -411 | -114 | N/A |
| Other Investing Activity | 0 | 0 | -411 | -114 | 0 |
| Investing Cash Flow | $-170 | $N/A | $206 | $580 | $-142 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 623 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | -2 | -1 | N/A |
| Common Stock Issued | 87 | N/A | 3,963 | 852 | 805 |
| Financing Cash Flow | $710 | $N/A | $3,961 | $851 | $805 |
| Exchange Rate Effect | -10 | N/A | 30 | 25 | 2 |
| Beginning Cash Position | 900 | N/A | 405 | 405 | 470 |
| End Cash Position | 207 | N/A | 1,105 | 454 | 405 |
| Net Cash Flow | $-693 | $N/A | $700 | $49 | $-65 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,223 | N/A | -3,497 | -1,407 | -730 |
| Capital Expenditure | -1 | N/A | -37 | -8 | -18 |
| Free Cash Flow | -1,224 | 0 | -3,534 | -1,415 | -748 |